Statistical methods for handling missing data in clinical trials during COVID-19
Posted @ 28 Sep, 2020With the ever-increasing number of clinical trials (the gold standard in new therapy evaluation) including those relating to ... Read More
Categories: Covid 19
Tags: Covid 19 Missing Data
Categories
Recent Posts
- Algorics names Amit M Patel to Board of Directors 03 Feb, 2023
- Expediting regulatory submissions with biometrics resourcing 17 Jan, 2023
- Delivering a complex ISS/ISE submission 23 Sep, 2022
- Supporting an emerging biotech with end-to-end data services for an oncology pro... 23 Sep, 2022
- LIVE WEBINAR- A Proactive Data Standards Strategy to Maximize Biopharma R&D Asse... 09 Sep, 2022
Tags
accelerating
advanced-therapies
agility
AI
Algorics
Analysis_Data_Standard
Automation
biometrics
BioNJ
biostatistics
Biotech
blog
Board_Announcement
Board_Of_Directors
Cancer
CDISC
celebrating-you
clinical-research
clinical-trials-day-2022
clinical_trials
community
Corporate_Announcement
COVID-19
COVID-19 Missing Data
CSV
data
Data journey
Data Strategy
dataautonomy
data_analysis
data_library
data_management
data_reporting
data_standardization
data_standards
data_visualisation
Decentralization
decentralizedtrials
Define.xml
digitalinfrastructure
DoubleProgramming
drug development
early_evidence
efficacy_analysis
efficiency
embedded
FDA
FSP
futureready
Growth
Infrastructure
ISE
ISS
metadata
MetaVate
Missing data
New_Addition
Oncology
optimization
pandemic
Partnering
PatientInsights
patient_safety
PharmaSUG
Phuse
post-pandemic
Press
Press Release
programming
Q&A
regulatory
release
Research
resourcing
risk-based
risk_management
safety
safety_insights
Statistics
Story
Submission
submission_ready
surveillance
Test
US
Visual
Visualization
Webinar